Alexander Ozerov - stock.adobe.com.
More on medications
Four red flags and one truth amid the peptide hype
Under Trump, FDA seeks to abandon expert reviews of new drugs
FDA releases denial letters for unapproved drugs, a step toward transparency
CSPI urges removal of ineffective oral decongestant phenylephrine from market
Prediabetes: What may—and may not—help reverse it?